Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Outline of Final Research Achievements |
Our aim to investigate is to establish the new approach for glioblastoma. We demonstrated that combination therapy with gamma delta T cell and bisphosphonate had a significant strong anti-tumor effect for transplanted glioblastoma cells into NOG mouse. In second experiment, we demonstrated that NK cells had a strong anti-tumor effect for temozolomide-resistant glioblastoma cells in vitro. In conclusion, gamma delta T cell and NK cells are promising cell source for glioblastoma.
|